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Abstract: Pituitary adenylate cyclase activating polypeptide (PACAP) is a neuropeptide with 
diverse developmental roles, including differentiation of skeletal elements. It is a positive regulatory 
factor of chondrogenesis and osteogenic differentiation in vitro, but little is known about its in vivo 
role in bone formation. In our experiments, diaphyses of long bones from hind limbs of PACAP 
gene-deficient mice showed changes in thickness and increased staining intensity. Our main goal 
was to perform a detailed morphological and molecular biological analysis of femurs from PACAP 
knockout (KO) and wild type (WT) mice. Transverse diameter and anterior cortical bone thickness 
of KO femurs showed significant alterations with disturbed Ca2+ accumulation and collagen type I 
expression. Higher expression and activity of alkaline phosphatase were also observed, 
accompanied by increased fragility PACAP KO femurs. Increased expression of the elements of 
bone morphogenic protein (BMP) and hedgehog signalling was also observed, and are possibly 
responsible for the compensation mechanism accounting for the slight morphological changes. In 
summary, our results show that lack of PACAP influences molecular and biomechanical properties 
of bone matrix, activating various signalling cascade changes in a compensatory fashion. The 
increased fragility of PACAP KO femur further supports the role of endogenous PACAP in in vivo 
bone formation. 
Keywords: hedgehog; BMP; collagen expression; inorganic matrix; alkaline phosphatase activity; 
bone fragility 
 
1. Introduction 
Molecular mechanisms regulating bone development and regeneration have been intensely 
studied over the last two decades, but still there are several signalling pathways with less-understood 
functions in these fields [1]. Morphology and stability of long bones determine the size, strength and 
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motility of animals. Subsequently, the maintenance of a proper inorganic and organic matrix 
composition and turnover is essential for the appropriate biomechanical function of long bones [2]. 
Matrix production and its composition are crucial factors for adequate limb development and normal 
callus formation [3]. Development of long bones or the osteoprogenitor-osteoblastic transformation 
is regulated by various signalling mechanisms such as bone morphogenic protein (BMP), hedgehog 
(HH) and Wingless int1 (WNT) pathways [1,4]. The initial steps of osteogenesis are followed by the 
induction of bone specific matrix production, in which collagen type I is the major organic 
component. Orientation and thickness of collagen lamellas together with inorganic components 
provide the specific architecture in cortical bone. This lamellar architecture ensures the biomechanical 
stability and the tensile strength of compact bone [5]. Besides the production of the organic 
components of bone matrix, osteoblasts also take an active part in the calcification of bone matrix. 
Calcium hydroxyapatite deposits between the collagen lamellas and intercalation of calcium salt 
crystals in the periodic gaps of collagen fibrils provide the hardness of bone tissue [6]. 
For precise regulation of extracellular matrix (ECM) production, activation of osteoblasts 
requires a proper timing and milieu which can be triggered by cytokines, growth hormones or other 
endocrine/paracrine pathways [1]. BMP is one of the basic activators of bone development which can 
bind to BMPR (bone morphogenic protein receptor) and trigger the phosphorylation of Smad1/5 
followed by its nuclear translocation. This pathway induces the production of various proteins such 
as alkaline phosphatase (ALP), osterix or even collagen type I; all are essential to proper bone 
formation [7]. Furthermore, it has been demonstrated that BMPs activate the transcription factor 
cyclic adenosine monophosphate (cAMP) response element-binding protein (CREB) via the 
activation of protein kinase A (PKA) which also triggers the expression of molecules mentioned 
above [8]. On the other hand, bone formation is regulated by Runx2 transcription factor which can 
also be activated by PKA and it regulates the expression of bone specific molecules and ECM 
components [9]. At this point there is a putative link between pituitary adenylate cyclase activating 
polypeptide (PACAP) signalling and bone formation, as PKA is its first described and major 
intracellular mediator [10]. 
PACAP comprises 38 amino acid residues (PACAP 1-38) and a shorter α-amidated form that 
corresponds to the 27 residues of the N-terminus (PACAP 1-27) can also be generated. Its biologically 
active region is completely preserved during evolution [11]. The presence of the neuropeptide has 
been shown in several peripheral tissues, such as in gonads [12], intestine [13], kidney [14], or testis 
[15]. It has been demonstrated that PACAP can prevent the harmful effect of oxidative stress [16,17], 
trigger the activation of anti-inflammatory processes and can have a positive role during ischemic 
conditions [18]. PACAP is also known to activate the immune system [19] and to induce tissue 
regeneration [20]. It plays an important role in the development of different organs, regulates 
chondrogenesis and spermatogenesis [16], and influences the development of the central nervous 
system [10,21]. Numerous recent experiments have also proven the importance of PACAP in limb 
development [16,22,23]. 
PACAP has three major receptors, vasoactive intestinal polypeptide receptor (VPAC)1, VPAC2 
and pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1), the latter one of which 
has the highest affinity to the neuropeptide [10]. PAC1 and VPAC1 receptors have been proven to be 
expressed on UMR-106 osteoblast cells [24], while VPAC2 was detected in MC3T3E1 calvarial 
osteogenic cell lines [25]. Release of PACAP from sympathetic nerve endings in bone tissue has also 
been demonstrated [26]. In vitro it has a positive effect on calcification and bone matrix production 
[16,24]. PAC1 receptor is a G protein coupled receptor, which has several crosstalks with different 
signalling pathways [10,22]. Binding of PACAP receptors leads to the induction of PKA activation, 
the canonical signalling pathway of PACAP signalization. PKA can subsequently activate several 
transcription factors such as CREB, Runx2 or Sox9 [16,22,24]. The activation of PACAP receptors may 
form a signalization crosstalk with BMP, WNT or β-catenin pathways or have a negative regulatory 
connection with the Sonic Hedgehog (SHH) signalization [27]. Ca2+ dependent pathways can be 
activated via PAC1 receptors and intracellular Ca2+ release has been detected in the presence of 
PACAP [28]. 
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The importance of PACAP and its signalization has been proven in several tissues, but we do 
not have a clear picture about its role in long bone development. In this study we demonstrate the 
importance of PACAP in the regulation of matrix production in long bones. Furthermore, we 
analyzed the possible signalling crosstalk in wild type (WT) and PACAP KO mice, possibly 
modifying the biomechanical stability of cortical bone. 
2. Results 
2.1. Bone Morphology is Only Slightly Modified in PACAP Gene Deficient Mice 
First, anatomical alterations were investigated in hind limbs of PACAP gene-deficient mice. 
Interestingly hind limb bone morphology of PACAP KO mice was not significantly altered. No 
differences were detected in the length of femur or tibia, and no other anatomical alterations were 
visible (Figure 1A, Figure S3). No difference was found in the length of tibia with CT (computed 
tomography) analysis. Femur length of PACAP KO mice was tendentiously shorter but did not reach 
a significant level (Figure S2A,B). Randomly increased alizarin red intensity was detected as it is 
visible at the tip of arrows in Figure 1A. However, some thinner parts also appeared in the femur 
diaphyses of gene deficient mice (Figure 1A), but the optical density of the stained bone had no 
significant alterations in PACAP KO animals (Figure 1A, Figure S3). Therefore, further analysis was 
performed focusing on femurs. In cross sections of the diaphyses, the cortical part was thicker in 
PACAP KO animals than in WTs with hematoxilin-eosin (HE) staining (Figure 1B). The diameter of 
bone marrow cavities was wider in WT animals (Figure 1B) in sections from the same level. A CT 
analysis was performed to quantify the exact differences of cortical bone thickness and internal 
cavity. The proximal and distal epiphyses did not show any significant morphological differences, 
therefore only the diaphyses were further analyzed. Femur lengths were not significantly altered in 
PACAP KO mice (Figure S2A). Similarly, no significant differences were found in the posterior 
cortical area or in the sagittal diameters (Figure 1D). On the contrary, the anterior cortical bone was 
significantly thicker in the gene deficient animals (Figure 1C). Although the sagittal diameter of the 
diaphyses had no significant alterations, the transverse diameters were significantly shorter in 
PACAP KO mice (Figure 1E,F). Further analysis of the CT results did not show any other significant 
alterations, only the density of the femur at the level of greater trochanter was tendentiously lower 
in PACAP KO animals (Figure 1G), suggesting certain alterations in the bone matrix of KO animals. 
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Figure 1. Morphological analysis of hind limbs of wild type (WT) and pituitary adenylate cyclase 
activating polypeptide (PACAP) knockout (KO) mice. Whole limb alizarin red staining (A), optical 
density (OD) was determined in 1 cm distal part of the femur. Hematoxilin-eosin (HE) staining (B) to 
visualize the histological differences. Original magnification was 4×. Scale bar, 500 µm. CT analysis 
(C–G) of mouse femurs. Representative data of 5 independent experiments. Asterisks indicate 
significant (* p < 0.05) difference in thickness of cortical bone or in the diameter of diaphysis compared 
to the respective control. 
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2.2. Inorganic Matrix Production is Disturbed in PACAP KO Mice 
In further steps, the inorganic matrix component of femur diaphyses was investigated in detail. 
To visualize the Ca2+ content of bone ECM von Kossa and alizarin red stainings were performed. A 
remarkable inhomogeneity in Ca2+-phosphate content of the diaphyses in certain parts of the KO 
femurs was observed (Figure 2A). The femurs contained more Ca2+ phosphate closer to the distal end 
of the diaphyses, while the proximal parts had reduced Ca2+ content in KO compared with WT mice 
(Figure 2A, Figure S4A). Although these differences were visible with alizarin red staining, the whole 
femur did not have any macroscopical disorders. In order to explore the possible background 
molecular mechanisms, expression levels of enzymes responsible for matrix production in bone were 
followed with molecular biological methods. mRNA expression was altered (Figure 2C, Figure S4B) 
and protein expressions of alkaline phosphatase (ALP) and its target molecule, osterix, were 
significantly elevated in PACAP deficient animals (Figure 2D, Figure S4C). Moreover, other matrix 
molecules, such as osteocalcin and osteopontin, which can be related to the altered inorganic bone 
matrix deposition, showed increased expression in KO mice (Figure 2D, Figure S4C). Their mRNA 
expression did not show alterations (Figure 2C, Figure S4B). As protein expression is not always in 
direct relation with the enzyme activity, ALP activity was also assayed and a dramatic increase was 
detected in femur samples of PACAP KO mice (Figure 2E). 
 
Figure 2. Investigation of inorganic matrix production of long bones. von Kossa (A) and alizarin 
red(B) staining of cryosectioned samples. Original magnification was 4×. Scale bar: 500 µm. Optical 
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density (OD) was determined in microphotographs and normalised to wild type samples. mRNA (C) 
and protein (D) expression of alkaline phosphatase (ALP), osterix, osteocalcin and osteopontin of 
femurs. For reverse transcription followed by polymerase chain reaction (RT-PCR) and Western blot 
reactions, actin was used as control. Optical signal density was measured and results were normalised 
to the controls. For panels (C) and (D) numbers below signals represent integrated signal densities 
determined by ImageJ software. (E) ALP activity in compact bone. Asterisks indicate significant (* p 
< 0.05) alteration of ALP activity compared to the respective control. Representative data of 3 
independent experiments. 
2.3. Augmented Collagen Type I Expression in PACAP KO Mice 
Morphology of the femur was not altered in spite of the elevated inorganic bone matrix 
production, therefore, further analysis of organic matrix production was performed. Orientation of 
collagen type I-made fibers in a cortical lamella is a crucial factor in determining the microscopical 
structure and macroscopic morphology of compact bone. Therefore, this organic component of 
compact bone was further investigated. Concentric lamellae of compact bone were found thicker in 
PACAP gene deficient mice shown with picrosirius red staining in polarization microscope (Figure 
3A). Collagen fibers in WT animals were present, although they seemed to be thinner (Figure 3A, 
Figure S5A). Furthermore, the immunohistochemical analysis verified the previous results (Figure 
3B, Figure S5B): concentric collagen lamellas were visualised in both experimental groups with 
stronger signals of PACAP KO mice (Figure 3B). Immunopositivity around the osteocytes had no 
significant differences between WT and KO mice (Figure 3B, Figure S5B). To detect the total 
expression of collagen type I, reverse transcription followed by polymerase chain reaction (RT-PCR) 
and Western blot were performed. mRNA expression of the major organic extracellular matrix 
component was elevated in PACAP gene deficient animals (Figure 3C, Figure S5C), and a 
dramatically increased protein expression was also observed (Figure 3D, Figure S5D). 
 
Figure 3.Collagen type I expression in femurs. (A) Collagen expression of cortical bone was visualized 
with picrosirius staining, and photomicrographs were made by polarization microscope. Original 
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magnification was 20×. Scale bar: 200 µm. Numbers below the photos show the differences of 
concentric lamellas thickness. (B) Immunohistochemistry of collagen type I in cortical bones. Original 
magnification was 20×. Scale bar: 200 µm. mRNA (C) and protein (D) expression of collagen type I. 
For RT-PCR and Western blot reactions, actin was used as controls. Optical signal density was 
measured and results were normalised to the controls. For panels (C) and (D) numbers below signals 
represent integrated signal densities determined by ImageJ software. Asterisks indicate significant (* 
p <0.05) alteration of expression compared to the respective controls. Representative data of 3 
independent experiments. 
2.4. Alterations of PACAP Signalling Pathway in Cortical Bone 
As PACAP can act on three different receptors, we monitored mRNA and protein expressions 
of PAC1, VPAC1 and VPAC2 receptors. We were not able to detect the mRNA of VPAC1 receptor in 
cortical bone (Figure 4A). PAC1 receptor was expressed equally in PACAP KO and WT mice, while 
the protein expression of VPAC2 was elevated in gene deficient animals (Figure 4A,B, Figure S6A,B). 
The major downstream target of PACAP signalization is PKA, which was detected in both genotypes 
without significant differences in its expression (Figure 4A,B, Figure S6A,B). The most important 
transcription factors that are substrates of PKA, are CREB and Runx2 in bone development. 
Phosphorylation of CREB is regulated by PKA and a reduced amount of phospho-CREB was detected 
in PACAP KO mice, while mRNA expression of CREB was detected without alteration and the 
unphosphorylated protein of CREB was not altered significantly (Figure 4A,B, Figure S6A,B). 
Surprisingly, the mRNA and protein expression of Runx2 transcription factor was increased in bone 
samples of PACAP deficient mice (Figure 4A,B, Figure S6A,B). Moreover, a much higher level of 
nuclear Runx2 was detected in osteocytes of KO femurs (Figure 4C, Figure S6C). 
 
Figure 4. PACAP signalisation in bones. (A) mRNA and (B) protein expression of pituitary adenylate 
cyclase-activating polypeptide type I receptor (PAC1), vasoactive intestinal polypeptide receptor 
(VPAC)1, VPAC2,protein kinase A (PKA), cyclic adenosine monophosphate (cAMP) response 
element-binding protein (CREB), Runx2 in cortical bone. Actin was used as a control. Numbers below 
signals represent integrated signal densities determined by ImageJ software. Asterisks indicate 
significant (* p < 0.05) alteration of expression compared to the respective controls. Representative 
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data of 3 independent experiments. (C) Immunohistochemistry of Runx2 in cortical bones. Original 
magnification was 60×. Scale bar: 5 µm. Representative data of 3 independent experiments. 
2.5. Alterations of possible signalling crosstalks 
One of the major regulators of bone development is the BMP signalling cascade. Therefore, we 
investigated the ligands of BMPR1, which is known to play a crucial role in limb development [4]. 
No alterations were detected in the mRNA or protein expressions of BMP2 (Figure 5A,B, Figure 
S7A,B). Similarly, BMP4 protein expression had no difference between the two different genotypes, 
although BMP4 mRNA expression was tendentiously elevated in KO animals (Figure 5A, Figure 
S7A,B). BMPs, such as BMP6 and BMP7, playing fundamental roles in cortical bone formation, 
showed increased mRNA and significant protein expression elevation in PACAP KO mice (Figure 
5A,B, Figure S7A,B). Furthermore, BMPR1, the receptor of these BMPs showed higher mRNA and 
protein expression in the PACAP KO animals than in WT mice (Figure 5A,B, Figure S7A,B). 
Activation of BMP signalling can be judged by its downstream targets, such as Smad transcription 
factors. Although mRNA expression of Smad1 was tendentiously reduced in gene deficient mice 
(Figure 5A, Figure S7A), the protein expression was significantly elevated, almost doubled in the 
same samples (Figure 5B, Figure S7B). Smad1 nuclear localization is a sign of its activation, therefore, 
immunohistochemistry was performed. In the cortical bone of PACAP KO mice the nuclear 
localization of Smad1 was stronger in confocal series than in WT littermates (Figure 5C, Figure S7C). 
PACAP activation exerts an inhibitory effect on hedgehog signalling, which in turn influences 
extracellular matrix production and BMP expression. We monitored the molecular components 
contributing in the canonical way of hedgehog signalization. Both the mRNA and protein expression 
of Indian Hedgehog (IHH) and SHH increased in PACAP gene deficient bones (Figure 5D,E, Figure 
S7A,B). Likewise, the main receptor of these ligands, Patched (PTCH)1 also increased in the PACAP 
KO animals (Figure 5D,E, Figure S7A,B), and mRNA and protein expression of Gli1, the downstream 
target of the receptor activation, was elevated in gene-modified tissues (Figure 5D,E, Figure S7A,B). 
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Figure 5.Signalling connections of PAC1 receptor. mRNA (A,D) and protein (B,E) expression of bone 
morphogenic protein (BMP)2, BMP4, BMP6, BMP7, BMPR1, Smad1, Indian Hedgehog (IHH), Sonic 
Hedgehog (SHH), Patched (PTCH)1 and Gli1 in cortical bone. For RT-PCR and Western blot reactions, 
actin was used as controls. Signals optical density was measured and results were normalised to the 
optical density of controls. For panels (A,D) and (B,E) numbers below signals represent integrated 
densities of signals determined by ImageJ software. (C) Smad1 immunohistochemistry in bones. 
Original magnification was 60×. Scale bar: 5 µm. (F) Three point bending tests of long bones. (a) Value 
of the loading force at crack (Fm), and (b) the value of the bending deformation at crack (Δlm) were 
demonstrated. Asterisks indicate significant (* p < 0.05) alteration of expression as compared to the 
respective control. Representative results of 3 independent experiments. 
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2.6. Biomechanical Properties of Bones are Altered in PACAP KO Mice 
As we observed significantly altered BMP and HH signalization and imbalanced bone matrix 
composition in bone samples of PACAP KO mice without any obvious macroscopic morphological 
changes, we hypothesized that the bone tissue in KO femurs may have worse biomechanical 
properties compared to WT samples. Therefore, we performed bone fracture assays and measured 
two parameters. The force needed for a complete fracture at shafts of PACAP KO femur was 
significantly lower than in WT mice (Figure 5(Fa)). Reflection of the femur shafts had no significant 
differences between the two genotypes, although the bones from PACAP deficient mice had 
tendentiously higher inclination (Figure 5(Fb)). 
3. Discussion 
PACAP is a neuropeptide with important roles in several differentiation processes in the central 
nervous system and also in the periphery [10,29,30]. Our laboratory has already proven its 
importance during in vitro cartilage differentiation and we have also demonstrated its preventative 
function during oxidative stress [16] and mechanical load in chondrogenesis [27]. Presence of PACAP 
positive sympathetic fibers was detected in the epiphysial cartilage canals of pigs and as a 
neurohormone it can also reach bones via vessels [26]. In vitro studies have proven the presence of 
PACAP receptors in MC3T3E1 [25] and UMR 106 osteoblastic cell lines [24]. Although PACAP gene 
deficient mice do not have marked visible morphological alterations, their behavior and movement 
activity is slightly changed compared with the wild type animals [31]. 
In our experiments, we found only minor macroscopic differences in bone shape and size but 
the detailed CT analyses showed an increase of anterior cortical bone thickness and elevation of 
transverse diameter in the femur shafts in KO mice. The density of femur trochanter did not show 
significant alterations but it was tendentiously lower in PACAP gene deficient mice. As significant 
changes were detected mostly in the femur, therefore our main experiments were focused on this 
bone. Disorders of femur signalling pathways result in an alteration of bone microarchitecture, 
subsequently, fracture characteristics and mechanical load bearing of long bones may decrease 
[32,33]. 
To investigate the molecular mechanisms in the background of cortical bone histological 
alterations, we focused on the signalling pathway of PACAP and putative signaling crosstalks. It has 
been demonstrated that the lack of Gα protein reduces bone mass in mice [34].As PAC1 receptor is a 
G protein coupled receptor, its inactivation may be involved in the generation of an altered bone 
architecture. Since significant morphological changes were not visible at KO femurs, we 
hypothesized that the lack of PACAP signalling induced activation of unusual crosstalk of certain 
signalling molecules or evoked compensatory molecular mechanisms. PAC1 receptor was detected 
in WT and PACAP KO mice equally but the expression of its downstream elements was altered. 
Activation of PACAP receptors induces the elevation of intracellular cAMP concentration, 
subsequently triggering elevated activation of PKA, which is considered the classical downstream 
mechanism of PACAP signaling [10]. PKA can phosphorylate several transcription factors in skeletal 
tissue development, such as CREB, Sox9 [35,36] or Runx2 [24]. The nuclear translocation of these 
factors induces the activation of genes encoding extracellular matrix component proteins. The 
expression of PKA and CREB did not significantly change, but the more active, phosphorylated form 
of CREB decreased in gene deficient mice. Activation/phosphorylation of CREB is required for proper 
bone formation [37], but there are other transcription factors which can also be influenced by PKA 
signalling pathway and contribute to the regulation of osteogenesis. Runx2 can be activated via 
PACAP-PKA axis [24], which was increased in PACAP KO mice. This may suggest a PACAP 
dependent and independent activation of this transcription factor which may compensate the lack of 
CREB activation. On the other hand, Runx2 via the IHH activation also plays a role in ossification 
[38]. Both CREB and Runx2 can regulate the expression of collagenous and non-collagenous proteins 
building organic bone matrix and influencing deposition of inorganic components of compact bone 
(Figure 6). 
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First the inorganic component of the extracellular matrix of femur shafts was investigated in 
detail. We found focal and regional heterogeneity in the staining intensity of Ca2+ positive matrix 
areas in femur diaphyses of PACAP KO mice. These findings suggested disturbed ossification and 
local architectural disorders of cortical bone, which may result in altered biomechanical properties of 
the femurs of PACAP gene deficient animals [39]. In line with these findings, we reported structural 
changes in hard tissues of the teeth of PACAP KO mice [40]. Another finding supporting disturbed 
bone mineralisation was the significantly elevated protein expression and activity of ALP in cortical 
bone tissue samples of PACAP KO femurs. Expression of bone matrix non-collagenous proteins such 
as osterix and osteocalcin, which play a substantial role in inorganic matrix binding to the organic 
matrix, was also found elevated in the same samples. Bone specific ALP is one of the most important 
signalling elements which can determine the matrix composition of cortical bone [41]. Although we 
did not investigate the tissue distribution of these proteins, but heterogeneity in the staining intensity 
of the calcified matrix suggests that the above bone matrix proteins are probably not equally 
distributed in the cortical bone of femurs, resulting in focal matrix deposition disorders. Similar 
phenomena appear during aging or mechanical loading in bone matrix production [42]. Induction of 
the transcription of ALP gene can occur via Runx2 [43], and we observed that expression and nuclear 
localization of this transcription factor was significantly higher in gene deficient mice. 
Subsequently, ALP activation can affect collagen secretion by osteocytes and osteoblasts [41]. In 
gene-deficient mice we detected an elevated collagen type I expression and altered lamellar structure 
in compact bone. The increased accumulation of collagen type I can be a good marker of 
biomechanical characteristics of long bones [44]. Collagen type I has special spiral orientation in 
cortical bone lamellae. Alterations in collagen fiber orientation in lamellae may have an effect on 
strength of bone or on callus formation which strongly influences bone stability and biomechanical 
properties [6]. In chronic arthritis the expression and remodelling of collagen type I is altered, which 
results in an increased fragility of bones [45]. Taken together, the proper orientation and expression 
level of collagen type I is essential for the stability of long bones. Indeed, when we investigated 
whether these alterations in bone matrix production had any negative effect on biomechanical 
properties of shafts of KO femurs we found that significantly lower force was needed for bone 
fracture examining KO bones. 
As both the organic and inorganic components of bones were altered without major 
morphological disorders, some compensatory changes in the activity of various regulatory 
mechanisms are supposed, which are physiologically influenced by PACAP signalling. We have 
shown a PACAP induced Runx2 nuclear accumulation in UMR-106 cell line [24]. PACAP deficient 
mice also showed an elevated nuclear presence of Runx2, which suggests a PACAP independent 
activation (Figure 6). It is known that osteogenic differentiation can be regulated by 
BMP/Runx2/osterix axis as BMP2 can activate Runx2, which in turn can regulate osterix expression 
[9]. PACAP signalisation exerts effects on several, putatively crosstalking downstream signalling 
pathways, such as WNT, β-catenin, hedgehog and BMP [22,27]. First, we focused on BMP signalling 
and found elevated mRNA expression of BMP4, 6 and 7, while protein levels only of BMP6 and 7 
were higher in PACAP KO mice. No alterations were shown in either the mRNA or protein 
expression of BMP2. BMP7 and BMP2 have a direct connection with the activation of Runx2 
expression [9,46,47], but their action exhibits differences [48]. BMP7 can directly induce the 
expression of Runx2 but does not regulate the matrix production similarly to BMP2 [48]. It was 
reported that BMP7 addition increased the activity of ALP in MC3T3 cultures [49]. This observation 
may imply that inhibition of PACAP receptors has direct connection with BMP7 expression. On the 
other hand BMP6, the most potent among the BMPs, regulates the osteogenic differentiation and its 
elevated expression increased the expression of ALP, osterix, osteocalcin and osteopontin [50]. We 
have already demonstrated that mechanical load of chondrifying cell cultures had a direct connection 
with PACAP signalling [22]. It induced the expression of collagen type X, a characteristic collagen 
synthesized by hypertrophic chondrocytes during calcification of cartilage matrix, preceding 
ossification or establishing the interface of articular cartilage and subchondral bone [27]. It is also 
known that expression of BMP6 and BMP7 is upregulated during mechanical load in subchondral 
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bone [51]. Our results suggest that BMP6 and BMP7 have partly escaped from the control or fine 
tuning effects of PACAP signalling pathway and induced the nuclear translocation of Smad1 
transcription factor (Figure 6). This pathway also has an influence on ALP activity, which became 
probably randomly over-activated and generated focal enhancement of mineralization (Figure 6). If 
these changes occurred without modulation of the activity of any compensatory mechanisms, 
abnormal bone development and bone morphological disorders would be expected. Nonetheless, the 
macroscopical characteristics of KO femurs showed only minor alterations. Therefore, it is suggested 
that BMP over-activation triggers or becomes balanced by another compensatory signalling 
mechanism. One of these compensatory mechanisms can be the hedgehog signalling, which has a 
direct connection with PACAP signalisation [27] and also has connection with BMP activation [52]. 
The activation of PKA induces inhibition of SHH signalling [53], so the absence of PACAP reduces 
PKA activation, which in turn triggers the over-activation of SHH signalling. The elevated BMP6 and 
BMP7 expressions in PACAP KO mice may have a direct contact with SHH activation, inducing an 
approximately normal bone differentiation and formation (Figure 6). Additionally, the expression of 
IHH was also increased in PACAP KO mice, and it can also be activated by BMPs [54].The expression 
of IHH can be regulated by BMPs [55] and induces the activation of long bone development. 
Moreover, Runx2 can have a direct communication with IHH [38]. In chondrogenic cultures we have 
also shown that the addition of PACAP decreased while mechanical load elevated the expression of 
IHH [27]. Subsequently, the increased IHH expression may be responsible for compensatory 
mechanisms, suggesting that PACAP has a negative correlation with IHH activation (Figure 6). 
Adding together SHH and IHH elevation triggers the action of Gli1, which results in an active bone 
differentiation process (Figure 6). 
In summary, we can conclude that PACAP signalisation is active during long bone development. 
Moreover, its activation has an important function in the fine tuning of crosstalk between several 
signalling pathways which are responsible for the formation of anatomically correct femur 
morphology. These signalling connections keep the appropriate balance of proper secretion of 
organic and inorganic components, which ensure the mechanical properties of long bones. Therefore, 
disturbance of PACAP expression implies an altered fragility of cortical bone tissue which may also 
indicate its possible importance in various bone formation disorders. 
 
Figure 6. Schematic drawing of the possible signalling pathways regulated by PACAP in bone 
formation. PAC1 receptor activation leads to the increase of intracellular cAMP, which activates PKA. 
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Downstream targets of PKA can be CREB or Runx2 transcription factors which activations induce the 
expression of collagen type I, osterix, osteocalcin, ostepontin and ALP. BMP6 and BMP7 binding to 
BMPR1 triggers the activation of Smad cascade which can induce the expression of collagen type I, 
osterix, osteocalcin, ostepontin, ALP and IHH. The activation of BMP signalling is fine-tuned by the 
activation of PACAP signalling. Runx2 phosphorylation can occur via BMPR1 activation, showing a 
PACAP independent mechanism. IHH and SHH activate Gli1 transcription factor which is inhibited 
by PACAP signalling. This signalling pathway is also responsible for the activation of collagen type I 
and ALP expression. Increased ALP expression and activation elevates the Ca2+ phosphate 
production. PACAP signalling keeps a balance between BMP and hedgehog signalling activation via 
this regulates proper bone formation. 
4. Materials and Methods 
4.1. Animals 
Generation and maintenance of the PACAP-deficient mice on the CD1 background has been 
described in detail [56,57]. They were backcrossed at least for ten generations with the CD1 strain. 
Genotype was tested with PCR reactions. For the experiments we sacrificed1-month-old wild-type 
(WT, n = 18, n = 10 male, n = 8 female) and homozygous PACAP-deficient (PACAP KO, n = 18, n = 10 
male, n = 8 female) mice. Animals were fed and watered ad libitum, under light/dark cycles of 12/12 
h. All procedures were performed in accordance with the ethical guidelines approved (2 January 
2012.) by the University of Pécs (permission number: BA02/2000-24/2011). 
4.2. Whole Limb Alizarin Staining 
Hind limbs were removed and only the skin was peeled off. The entire limb was washed in PBS 
three times and fixed in a 4:1 mixture of absolute ethanol and 40% formaldehyde. After washing in 
alcohol limbs were incubated in 30, 60 and 80 mM KOH solution for 3 days, 2 days and 1 day, 
respectively, till the tissues became completely glossy. Residual KOH was removed by washing in 
PBS three times and samples were stained with alizarin red (Sigma-Aldrich, Saint Louis, MO, USA) 
for 15 min. Limbs were washed in the concentrated glycerine to remove unbound staining. Photos 
were made by an Olympus camera, scale was used to demonstrate size differences of hind limbs. 
Optical density of 1 cm of distal part of femurs was measured by using ImageJ 1.40g freeware and 
results were normalised to the optical density of wild type samples. 
4.3. Staining Procedure of Calcificated Tissue 
Femurs were dissected and additional tissues were removed. Samples were immediately fixed 
in 4% paraformaldehyde dissolved in 0.1 M phosphate buffer (PB) for 24 h at room temperature. 
Tissue was then washed in 0.1 MPB, and cryoprotected in 10% sucrose for 1 h, 20% sucrose in 
phosphate-buffered saline (PBS) overnight at 4 °C. For cryostat sectioning, the bones were embedded 
in tissue freezing medium (Tissue-Tek, OCT Compound, Sakura Finetech, Zoeterwade, The 
Netherlands), cut in a cryostat (Leica, Nussloch, Germany) using a blade for hard tissues. 20–30 serial 
sections were made from each femur. Sections were mounted on chrome–alum–gelatin-coated 
subbed slides. Samples were washed three times in PBS and stained with alizarin red (Sigma-Aldrich) 
for 5 min to evaluate calcium-rich deposits. Calcium phosphate deposition as sign of 
biomineralization was followed with von Kossa method (Millipore, Billerica, MA, USA). After 
washing in PBS, samples were incubated in 1% AgNO3 solution for 40 min. Slides were removed and 
exposed to UV for 10 min. Nitrate solution was removed with washing in PBS three times followed 
by incubation in 5% Na2S2O3 solution for 10 min. Slides were covered with gum arabic. 
Photomicrographs were taken using an Olympus DP72 camera on a Nikon Eclipse E800 microscope 
(Nikon Corporation, Tokyo, Japan). Optical density of photos was measured by using ImageJ 1.40g 
freeware and results were normalised to the optical density of wild type bone. 
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4.4. Staining Procedure of Decalcified Samples 
Femurs were dissected and additional tissues were removed as previously described, washed in 
PBS three times and fixed in a 4:1 mixture of absolute ethanol and 40% formaldehyde. Bones were 
decalcified in 4% ethylene diamine tetra-acetic acid (EDTA) for four weeks till bones became soft. 
Then samples were dehydrated in ascending alcohol row and embedded in paraffin. 5µm of serial 
sections were made. After rehydration, hematoxilin eosin (Sigma-Aldrich) and picrosirius red 
(Sigma-Aldrich) stainings were performed. All of the staining protocols were carried out according 
to the instructions of manufacturer. Photomicrographs were taken using an Olympus DP72 camera 
on a Nikon Eclipse E800 microscope (Nikon Corporation). Picrosirius staining was analyzed with the 
polarization module of Nikon Eclipse E800 microscope. Thickness of lamellas was measured by using 
ImageJ 1.40g freeware. In 3 independent experiments 10 lamellas diameter were calculated and given 
in pixel unit. Results of wild type animals were compared with gene deficient mice where differences 
were given in percentage. 
4.5. Radiographic Analysis (Micro-CT Scan) 
Bruker SkyScan 1176 Micro CT Scanner is an X-ray computed tomography system for non 
invasive imaging of bone morphological parameters. CT scanner was calibrated 50 kV, 500 µA pitch. 
Reconstruction of the slides was performed by NRecon (1.6.10.4 version) and CTAn (1.15.4.0 version) 
(Bruker MicroCT, Kontich, Belgium) was used to evaluate them. Femur CT studies obtained by using 
this micro-CT. Radiographs were used to analyze femur cortical thickness in ventral and dorsal 
aspects and femur densitometry of PACAP KO and WT mice was also performed. Density was 
measured in the region of greater trochanter. Using general anesthesia with 1% Euthasol (0.7 µL/10 
g) the total femur length (mm) from the greater trochanter to the medial condyle was measured in 18 
KO and 18 WT mice. 
4.6. Measurement of Alkaline Phosphatase Activity 
After dissection of hind limbs, femur diaphysis was removed and opened to remove bone 
marrow from the sample. Cortical bone was washed in PBS three times and 100 µL Radio Immuno 
Precipitation Assay (RIPA)-buffer (150 mM sodium chloride; 1.0% NP40, 0.5% sodium deoxycholate; 
50 mM Tris, pH 8.0) containing protease inhibitors (Aprotinin (10 µg/mL), 5 mMBenzamidine, 
Leupeptin (10 µg/mL), Trypsine inhibitor (10 µg/mL), 1 mM PMSF, 5 mM EDTA, 1 mM EGTA, 8 mM 
Na-Fluoride, 1 mM Na-orthovanadate) was added to each experimental group. Bone tissues were 
mechanically ground in liquid nitrogen (Cryo-Grinder, Nanotestkft., Budapest, Hungary) and 
sonicated by pulsing burst for 30 s at 40 A (Cole-Parmer, IL, USA). Protein concentration of samples 
was measured and equalized with BCA-protein assay (Pierce™, Rockford, MA, USA). ALP activity 
measurement was performed according the protocol of manufacturer. Results were measured on 420 
nm (Chameleon, Hidex Ltd., Turku, Finland). Activity of ALP was calculated according to the 
manufacturer’s protocol. Five independent measurements were used to demonstrate significant 
differences. 
4.7. Immunohistochemistry 
Femurs were dissected and additional tissues were removed. Briefly, bones were washed in PBS 
three times and fixed in Saint-Marie’s fixative (99% ethanol and 1% anhydrous acetic acid) for 24 h. 
The bones were decalcified in 4% EDTA for four weeks until the bones became soft. Then samples 
were dehydrated in descending alcohol row and embedded in paraffin. 5 µm serial sections were 
made. Sections were rehydrated in ascending alcohol row and washed in PBST (phosphate buffered 
saline supplemented with 1% Tween-20) three times. Nonspecific binding sites were blocked in PBST 
supplemented with 1% bovine serum albumin (BSA, Amresco LLC, Solon, OH, USA) at 37 °C for 30 
min. 
For collagen type I, Smad1 and Runx2 immunohistochemistry sections were incubated in anti-
Collagen type I. (Sigma-Aldrich) at a dilution of 1:500, in anti-Smad1 (Cell Signaling, Danvers, MA, 
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USA) at a dilution of 1:600, and anti-Runx2 (Cell Signaling, Danvers, MA, USA) at a dilution of 1:600 
at 4°C overnight. Primary antibodies were visualised with anti-rabbit Alexa555 and/or anti-mouse 
Alexa488 secondary antibodies (Life Technologies Corporation, Carlsbad, CA, USA) at a dilution of 
1:1000.Slides were mounted in Vectashield Hard Set mounting medium (Vector Laboratories, 
Peterborough, UK) containing DAPI to visualise the cell nuclei. Photomicrographs of collagen type I 
were taken using an Olympus DP72 camera on a Nikon Eclipse E800 microscope (Nikon Corporation, 
Tokyo, Japan). Images were acquired using cellSense Entry 1.5 software (Olympus, Shinjuku, Tokyo, 
Japan) with constant camera settings to allow comparison of fluorescent signal intensities. For 
investigation of subcellular localization of Smad1 and Runx2 fluorescent images were taken with an 
Olympus FV1000S confocal microscope (Olympus Co. Tokyo, Japan) using 40× oil immersion 
objective (NA: 1.3). For excitation, laser lines of 543 nm and 488 nm were used. The average pixel 
time was 4 µs. Z image series of 1 µm optical thickness were recorded in sequential scan mode. 
Images of Alexa555 and DAPI were overlaid using Adobe Photoshop version 10.0 software. 
4.8. RT-PCR analysis 
In liquid nitrogen femurs were cryo-ground and collected in TriReagent (Applied Biosystems, 
Foster City, CA, USA). 20% RNase free chloroform was added to the dissolved samples and followed 
by a centrifugation at 4 °C at 10,000×g for 15 min. Samples were incubated in 500 µL of RNase-free 
isopropanol at −20 °C for 1 h then total RNA was harvested in RNase free water and stored at −20 °C. 
For reverse transcriptase reaction the assays contained 2 µg RNA, 0.112 µM oligo(dT), 0.5 mM 
deoxynucleotide triphosphate (dNTP), 200 units of High Capacity RT (Applied Bio-Systems, 
Waltham, MA, USA) in 1× RT buffer and RT reaction was run in a thermal cycler (Labnet MultiGene™ 
96-well Gradient Thermal Cycler; Labnet International, Edison, NJ, USA). Sequences of primer pairs, 
amplimer sizes and further details are given in Table 1. Amplifications were performed in a thermal 
cycler (Labnet MultiGene™ 96-well Gradient Thermal Cycler; Labnet International). Final volume of 
assay mixture was 21 µL (containing 1 µL forward and reverse primers [0.4 µM], 0.5 µL dNTP [200 
µM], and 5 units of Promega GoTaq® DNA polymerase in 1× reaction buffer) and protocols were set 
as follows: 95 C, 2 min, followed by 35 cycles (denaturation, 94 C, 1 min; annealing at optimised 
temperatures as given in Table 1 for 1 min; extension, 72 C, 90 s) and then 72 C, for 10 min. 
Amplimers were analysed in 1.2% agarose gel containing ethidium bromide. Actin was used as 
internal control. Optical density of signals was measured by using ImageJ 1.40 g freeware and results 
were normalised to the optical density of control tissue. 
Table 1. Nucleotide sequences, amplification sites, GenBank accession numbers, amplimer sizes and 
PCR reaction conditions for each primer pair are shown. 
Gene Primer 
Nucleotide Sequence 
(5′→3′) 
GenBank ID 
Annealing 
Temperature 
AmplimerSize 
(bp) 
Alkaline 
phosphatase 
(Alpl) 
sense 
GAA GTC CGT GGG 
CAT CGT 
(474–491) 
NM013059 
 
59 °C 347 
antisense 
CAG TGC GGT TCC 
AGA CAT AG 
(801–820) 
   
BMP2 
(Bmp2) 
sense 
AAG CCA GGT GTC 
TCC AAG 
(697–714) 
NM017178.1 53 °C 209 
antisense 
AAG TCC ACA TAC 
AAA GGG TG 
(886–905) 
   
BMP4 
(Bmp4) 
sense 
TAG TCC CAA GCA 
TCA CCC 
(876–893) 
NM012827.2 53 °C 294 
antisense 
TCG TAC TCG TCC 
AGA TAC AAC 
(1149–1169) 
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BMP6 
(Bmp6) 
sense 
CCC AGA TTC CTG 
AGG GTG A 
(936–954) 
NM013107.1 56 °C 248 
antisense 
CAT GTT GTG CTG 
CGG TGT 
(1166–1183) 
   
BMP7 
(Bmp7) 
sense 
AGG GAG TCC GAC 
CTC TTC T 
(607–625) 
NM001191856.1 54 °C 297 
antisense 
GTT CTG GCT GCG TTG 
TTT 
(886–903) 
   
BMPR1 
(Bmpr1a) 
sense 
CCA TTG CTT TGC CAT 
TAT 
(240–257) 
NM009758.4 47 °C 487 
antisense 
TTT ACC AAC CTG 
CCG AAC 
(709–726) 
   
Collagen type I 
(Col1a1) 
sense 
GGG CGA GTG CTG 
TGC TTT 
(348–365) 
NM007742.3 60 °C 
388 
 
antisense 
GGG ACC CAT TGG 
ACC TGA A 
(717–735) 
   
CREB 
(Creb1) 
sense 
AGA TTG CCA CAT 
TAG CCC 
(95–112) 
NM031017.1 52 °C 441 
antisense 
GCT GTA TTG CTC CTC 
CCT 
(518–535) 
   
Actin 
(Actb) 
sense 
 
GCC AAC CGT GAA 
AAG ATG A 
(419–437) 
NM007393.5 54 °C 
462 
 
antisense 
CAA GAA GGA AGG 
CTG GAA AA 
(861–880) 
   
Gli1 
(Gli1) 
sense 
 
CCA CCC TAC CTC 
TGT CTA TTC G 
(2201–2222) 
NM010296.2 49 °C 
423 
 
antisense 
CAC CCT TGT TCT GGT 
TTT ACC 
(2603–2623) 
   
IHH 
(Ihh) 
sense 
CCA ACT ACA ATC 
CCG ACA TCA 
(248–268) 
NM053384.1 58 °C 477 
antisense 
GTC TTC ATC CCA 
GCC TTC C 
(390–408) 
   
Osterix 
(Sp7) 
sense 
GCC TAC TTA CCC 
GTC TGA CTT T 
(525–543) 
NM001037632.1 56 °C 131 
antisense 
GCC CAC TAT TGC 
CAA CTG C 
(634–652) 
   
Osteocalcin 
(Bglap2) 
sense 
TAA GGT GGT GAA 
TAG ACT CCG 
(123–143) 
NM013414.1 56 °C 143 
antisense 
CCT GGA AGC CAA 
TGT GGT 
(248–265) 
   
PAC1 
(ADCYAP1R1) 
sense 
CTA CGC CCT TTA 
CTA CCC AG 
(210–229) 
NM016989.2 49 °C 247 
antisense 
GTA TTT CTT GAC 
AGC CAT TTG T 
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(435–456) 
PKA 
(Prkaca) 
sense 
GCA AAG GCT ACA 
ACA AGG C 
(847–865) 
NM008854 53 °C 280 
antisense 
ATG GCA ATC CAG 
TCA ATC G 
(1109–1126) 
   
Osteopontin 
(Spp1) 
sense 
GCT GAA GCC TGA 
CCC ATC T 
(126–144) 
X51834 59 °C 494 
antisense 
TCC CGT TGC TGT CCT 
GAT 
(602–619) 
   
PTCH1 
(Ptch1) 
sense 
GGA ACT TAT CAC 
GGA GAC AG 
(579–578) 
NM053566.1 56 °C 368 
antisense 
AAC CTT GAC ATC 
CAC CAT T 
(928–946) 
   
Runx2 
(Runx2) 
sense 
GGA CGA GGC AAG 
AGT TTC A 
(598–616) 
NM001278483.1 55 °C 249 
antisense 
TGG TGC AGA GTT 
CAG GGA G 
(828–846) 
   
SHH 
(Shh) 
sense 
TCG TGC TAC GCA 
GTC ATC G 
(1042–1060) 
NM017221.1 56 °C 156 
antisense 
CCT CGC TTC CGC 
TAC AGA 
(1180–1197) 
   
Smad1 
(Smad1) 
sense 
AGC ACC TAC CCT 
CAC TCC C 
(935–953) 
NM013130.2 56 °C 306 
antisense 
GAA ACC ATC CAC 
CAA CAC G 
(1222–1240) 
   
VPAC1 
(VIPR1) 
sense 
GTT CTA TGG CAC 
GGT CAA 
(376–393) 
NM001097523 52 °C 216 
antisense 
AGC AAT GTT CGG 
GTT CTC 
(573–590) 
   
VPAC2 
(VIPR2) 
sense 
TCG GAA CTA CAT 
CCA TCT 
(477–497) 
NM001014970 48 °C 177 
antisense 
TTT GCC ATA ACA 
CCA TAC 
(636–653) 
   
4.9. Western Blot Analysis 
Tissues were cryo-grinded in liquid nitrogen. After centrifugation, tissue pellets were suspended 
in 100 µL of homogenization RIPA. Samples were stored at −70 °C. Suspensions were sonicated by 
pulsing burst for 30 s at 40 A (Cole-Parmer, Vernon Hills, IL, USA). For Western blotting, total cell 
lysates were used. Samples for SDS-PAGE were prepared by the addition of Laemmli electrophoresis 
sample buffer (4% SDS, 10% 2-mercaptoehtanol, 20% glycerol, 0.004% bromophenol blue, 0.125 M 
Tris HCl pH 6.8) to cell lysates to set equal protein concentration of samples, and boiled for 10 min. 
About 40 µg of protein was separated by 7.5% SDS-PAGE gel for detection of PAC1, VPAC1, VPAC2, 
PKA, ALP, osteocalcin, osteonectin, osterix, CREB, P-CREB, collagen type I, Runx2, BMP2, BMP4, 
BMP6, BMP7, BMPR1, Smad1, SHH, IHH, PTCH1 and Gli1. Proteins were transferred 
electrophoretically to nitrocellulose membranes. After blocking with 5% non-fat dry milk in 
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phosphate buffered saline (PBST) with 0.1% Tween 20, membranes were washed and exposed to the 
primary antibodies overnight at 4 C in the dilution as given in Table 2. After washing for 30 min in 
PBST, membranes were incubated with anti-rabbit IgG (Bio-Rad Laboratories, Hercules, CA, USA) in 
1:1500, anti-goat IgG (Sigma-Aldrich) in 1:2000 and anti-mouse IgG (Bio-Rad Laboratories) in 1:1500 
dilution. Signals were detected by enhanced chemiluminescence (PierceTM) according to the 
instructions of the manufacturer. Signals were developed on X-ray films and documented by gel 
documentary system (Fluorchem E, ProteinSimple, Santa Clara, CA, USA). For negative or positive 
controls to test antibodies brain, testis and cartilage were used from WT animals (Figure S4D,5E,6D). 
Optical density of Western blot signals was measured by using ImageJ 1.40g freeware and results 
were normalised to that of control samples. 
Table 2. Tables of antibodies used in the experiments. 
Antibody Host Animal Dilution Distributor 
Anti-PAC1 rabbit, polyclonal, 1:600 Sigma-Aldrich, St. Louis, MO, USA 
Anti-VPAC1 rabbit, polyclonal, 1:800 Alomone Labs., Jerusalem, Israel 
Anti-VPAC2 rabbit, polyclonal, 1:600 Abcam, Camridge, UK 
Anti-Coll. I. mouse, monoclonal, 1:1000 Sigma-Aldrich, St. Louis, MO, USA 
Anti-CREB rabbit, polyclonal, 1:800 Millipore, Billerica, MA, USA 
Anti-P-CREB rabbit, polyclonal, 1:800 Millipore, Billerica, MA, USA 
Anti-Osterix rabbit, polyclonal, 1:200 SantaCruz Biotechnology Inc., Santa Cruz, CA, USA 
Anti-Osteocalcin rabbit, polyclonal, 1:600 Abcam, Camridge, UK 
Anti-Osteopontin rabbit, polyclonal, 1:500 Abcam, Camridge, UK 
Anti-ALP rabbit, polyclonal, 1:500 Abcam, Camridge, UK 
Anti-SHH rabbit, polyclonal, 1:600 Cell Signaling, Danvers, MA, USA 
Anti-IHH rabbit, polyclonal, 1:600 Millipore, Billerica, MA, USA 
Anti-PKA rabbit, polyclonal, 1:800 Cell Signaling, Danvers, MA, USA 
Anti-Runx2 rabbit, polyclonal, 1:500 Cell Signaling, Danvers, MA, USA 
Anti-Gli1 rabbit, polyclonal, 1:600 Cell Signaling, Danvers, MA, USA 
Anti-BMP2 mouse, monoclonal, 1:500 Abcam, Camridge, UK 
Anti-BMP4 rabbit, polyclonal, 1:600 Cell Signaling, Danvers, MA, USA 
Anti-BMP6 rabbit, polyclonal, 1:200 SantaCruz Biotechnology Inc., Santa Cruz, CA, USA 
Anti-BMP7 rabbit, polyclonal, 1:600 Abcam, Camridge, UK 
Anti-BMPR1 mouse, monoclonal, 1:600 Abcam, Camridge, UK 
Anti-Smad1 rabbit, polyclonal, 1:600 Cell Signaling, Danvers, MA, USA 
Anti-PTCH1 rabbit, polyclonal, 1:800 Cell Signaling, Danvers, MA, USA 
Anti-Actin mouse, monoclonal, 1:10000 Sigma-Aldrich, St. Louis, MO, USA 
4.10. Fracture Test 
Three point bending tests were performed on mouse femurs using a Chatillon TCD225 tensile 
test machine. The center part of the bones was loaded by a 5 mm diameter cylindrical head (Figure 
S1A). Velocity of the head was 2 mm/min during the experiments. Value of the loading force at crack 
(Fm) as well as the value of the bending deformation at crack (Δlm) were evaluated from the 
deformation-force diagrams (Figure S1B). 
4.11. Statistical Analysis 
All data are representative of at least three different experiments. Where applicable, data are 
expressed as mean ± SEM. Statistical analysis was performed by Student’s t test. Threshold for 
statistically significant differences as compared to respective control (wild type animals) was set at * 
p < 0.05. 
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/xxx/s1. 
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Abbreviations 
ALP Alkaline phosphatase 
BMP Bone morphogenetic protein 
cAMP Cyclic adenosine monophosphate 
CNS Central nervous system 
CREB cAMP response element-binding protein 
DMEM Dulbecco’s Modified Eagle’s Medium 
dNTP deoxynucleotide triphosphate 
ECM Extracellular matrix 
EDTA Ethylene diamine tetra-acetic acid 
EGTA Ethylene glycol-bis(β-aminoethyl ether)-N,N,N’,N′-tetra acetic acid 
FBS Foetal bovine serum 
FGF Fibroblast growth factor; Gli, glioma-associated oncogene 
HH hedgehog 
HEPES 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid 
hMSC human mesenchymal stem cell 
IHH Indian Hedgehog 
MAPK Mitogen-activated protein kinase 
PAC1 Pituitary adenylate cyclase-activating polypeptide type I receptor 
PACAP Pituitary adenylate cyclase activating polypeptide, phosphate buffered saline 
PBST, Phosphate buffered saline supplemented with 1% Tween-20 
PLC Phospholipase C 
PKA Protein kinase A 
PKC Protein kinase C 
PTCH Patched 
RT-PCR Reverse transcription followed by polymerase chain reaction Runt-related transcription factor 2 
SHH Sonic Hedgehog 
TGFβ Transforming growth factor-β 
VIP Vasoactive intestinal polypeptide 
VPAC Vasoactive intestinal polypeptide receptor 
WNT Wingless int1 
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